EGFR and inclusion body myositis: Our recent microarray studies in muscle biopsies indicate that multiple signaling pathways are dysregulated in patients with VCP-associated inclusion body myopathy (IBM), which include abnormalities in actin cytoskeleton, ErbB signaling, cancer, regulation of autophagy and lysosomal signaling transduction cascades [38].